New York, NY -- (SBWIRE) -- 01/30/2013 -- Growing Stock Report adds Ventrus Biosciences Inc. (NASDAQ:VTUS) and Key Tronic Corp. (NASDAQ:KTCC) to their NASDAQ decliners watch list.
Ventrus Biosciences Inc. (NASDAQ:VTUS) a development stage specialty pharmaceutical company that focuses on the development and commercialization of late-stage prescription drugs for gastrointestinal disorders announced today the pricing of concurrent, separate underwritten offerings of 5,800,000 shares of its common stock at a price to the public of $2.50 for each share of common stock, for expected gross proceeds of approximately $14,500,000. The stock is down (-21.04%) as of this writing which prompted Growing Stock Report to add this stock to their Decliners watch list.
Click Here to find out what The Street and other Investors are saying about Ventrus Biosciences Inc.
Key Tronic Corp. (NASDAQ:KTCC) a company that together with its subsidiaries, provides electronic manufacturing services and solutions to original equipment manufacturers in the United States, Mexico, and China announced yesterday their results for the Second Quarter of Fiscal 2013, with quarterly Revenue Up 12% Year-over-Year and Net Income Up 13%. The stock is not acting favorably to this news, currently down (-18.64%) prompting Growing Stock Report to add Key Tronic Corp. (NASDAQ:KTCC) to their Nasdaq Decliners watch list.
Click Here to see what other investors are saying about Key Tronic Corp.
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Vipstockreport.com website, for complete risks and disclosures.
Contact Info:
Growing Stock Report
editor@GrowingStockReport.com
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)